Journal profile · Medicine-Immunology and Allergy
Immunological Medicine
ISSN 2578-5826 · Taylor & Francis · United Kingdom
Immunological Medicine: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.3 (journal website); fully open access; APC about USD 1,680; median 96 days to acceptance (97 articles, last 24 months); acceptance rate 31% (journal website); 50 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Immunological Medicine is published by Taylor & Francis and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Systemic Lupus Erythematosus Research, Rheumatoid Arthritis Research and Therapies and Immunodeficiency and Autoimmune Disorders, together about 26.1% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
Immunological Medicine is an international, peer-reviewed, open access journal publishing high-quality original research in clinical immunology. Immunological Medicine is the Official Journal of the Japanese Society of Clinical Immunology (JSCI). Recent progress in the field of clinical immunology has been remarkable. Many diseases and conditions, including autoimmune diseases, allergy-related diseases, infectious diseases, malignant diseases, immunodeficiency and transplantation-related conditions are associated with immunological abnormalities and require immunological approaches from various medical fields. Clinical immunology plays an increasingly important role as the bridge between basic research and clinical practice, with the significance of translational research rapidly increasing in recent years. Considering such developments, the society aims to publish an international and interdisciplinary journal for dissemination to a global audience. Immunological Medicine focuses on many diseases and conditions associated with immunological abnormalities that require immunological approaches from various medical fields, including: Autoimmune diseases Allergy-related diseases Infectious diseases Malignant diseases Immunodeficiency and transplantation-related conditions Immunological Medicine encourages the submission of original manuscripts covering a wide range of topics such as rheumatology, allergology, oncology, hematology, cardiology, neurology, respiratory medicine, gastroenterology, nephrology, dermatology, pediatrics and other medical topics that relate to both basic and clinical immunology. Immunological Medicine publishes original articles, review articles, case reports, and rapid communications article types. All submitted manuscripts, including invited review articles, are subject to single-anonymized peer-review by at least two independent, anonymous referees. To facilitate the peer-review process and subsequent publication of articles, the journal has a Transmitting Editor system in place. Transmitting Editors are responsible for the nomination of reviewers and for making the first decision of ‘accept’, ‘revision required’ or ‘reject’ on submitted manuscripts. The Editorial Board is responsible for the final decision of ‘accept’ or ‘reject’ on submitted manuscripts, and the subsequent order in which articles are published. All articles are made freely and permanently available online through gold open access publication.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Immunology and Allergy
Editor-in-chief Tatsuya AtsumiPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Systemic Lupus Erythematosus ResearchMedicine11%
- Rheumatoid Arthritis Research and TherapiesMedicine8.3%
- Immunodeficiency and Autoimmune DisordersImmunology and Microbiology6.8%
- Immune Cell Function and InteractionImmunology and Microbiology6.5%
- Autoimmune and Inflammatory Disorders ResearchMedicine6.5%
- Cancer Immunotherapy and BiomarkersMedicine5.4%
- T-cell and B-cell ImmunologyImmunology and Microbiology5%
- Inflammatory Myopathies and DermatomyositisMedicine5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Immunology | Zone 3 |
| Minor | Rheumatology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 2.3Publisher website ·
- CiteScore 2026-06
- 4.7LetPub ·
- CiteScore (publisher) 2025
- 4.7Publisher website ·
- SJR 2026-06
- 0.82LetPub ·
- SJR (publisher) 2025
- 0.82Publisher website ·
- SNIP 2026-06
- 0.74LetPub ·
- SNIP (publisher) 2025
- 0.74Publisher website ·
- h-index
- 30OpenAlex ·
- i10-index
- 100OpenAlex ·
- 2-year mean citedness
- 2.1OpenAlex ·
- Self-citation rate
- 4.3%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 47LetPub ·
- Downloads per year (publisher)
- 244,000Publisher website ·
Articles by year OpenAlex count · 319 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 50 | 50 | 8 |
| 2025 | 50 | 50 | 103 |
| 2024 | 46 | 46 | 196 |
| 2023 | 22 | 22 | 207 |
| 2022 | 21 | 21 | 213 |
| 2021 | 28 | 28 | 519 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
96 daysMedian, submission to acceptance · P25–P75 69 days – 137 days
- Acceptance to online
- median 10 days (97 articles)
- Submission to online
- median 108 days
- Sample
- 97 articles with submission and acceptance dates (111 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 19 weeksLetPub ·
- Acceptance rate (publisher)
- 31%Publisher website ·
- Submission to first decision
- 20 daysPublisher website ·
- First decision after review
- 30 daysPublisher website ·
- Acceptance to publication
- 9 daysPublisher website ·
- Submission to publication (journal-reported)
- about 19 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | GBP 1,344 / USD 1,680 | No | CC BY, CC BY-NC | |
| LetPub | GBP 1,344 / USD 1,680 | No | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted4
- case reportCase ReportLength not stated
- original articleOriginal ArticleLength not stated
- rapid communicationRapid CommunicationLength not stated
- review articleReview ArticleLength not stated
Policy excerpts from the journal's websiteOpen access, Peer review
- Open access Open access
Immunological Medicine is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discoverability and readership of your article Make an impact and reach new readers, not just those …
Source ↗Publisher website ·- Peer review
All submitted manuscripts, including invited review articles, are subject to single-anonymized peer-review by at least two independent, anonymous referees. Model summary
All submitted manuscripts, including invited review articles, are subject to single-anonymized peer-review by at least two independent, anonymous referees.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Taylor & Francis
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2578-5826
- Society / sponsor
- Japanese Society of Clinical Immunology
- Latest issue on the website
- Volume 49, Issue 3 (2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Immunological Medicine
What CAS zone is Immunological Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Immunological Medicine is in Zone 4 of Medicine, and in Zone 4 of the minor category Immunology / Rheumatology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Immunological Medicine?
The journal's website gives an impact factor of 2.3 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 4.7, h-index 30.
How long does peer review take at Immunological Medicine?
Based on the dates recorded on 97 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 96 days (interquartile range 69–137 days); authors report an average review time of about 19 weeks; the journal's website gives an acceptance rate of 31%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Immunological Medicine?
According to LetPub and DOAJ records, Immunological Medicine is indexed in ESCI, Scopus and DOAJ. The journal's website also lists PubMed; that list has not been checked against each database.
Is Immunological Medicine open access, and what is the APC?
Immunological Medicine is a fully open-access journal. APC about USD 1,680.
Sources and updates
The facts on this page come from LetPub, Publisher website, DOAJ, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .